https://wikimd.com/index.php?action=history&feed=atom&title=AcedapsoneAcedapsone - Revision history2026-04-09T09:00:17ZRevision history for this page on the wikiMediaWiki 1.44.2https://wikimd.com/index.php?title=Acedapsone&diff=5368919&oldid=prevPrab: CSV import2024-03-06T04:37:30Z<p>CSV import</p>
<p><b>New page</b></p><div>[[File:Acedapsone.png|thumb|{{PAGENAME}}]]<br>'''Acedapsone''' (also known as '''4-acetamido-4'-isothiocyanostilbene-2,2'-disulfonic acid''') is a [[sulfone]] derivative used in the treatment of [[leprosy]]. It is a long-acting, [[lipophilic]] derivative of [[dapsone]].<br />
<br />
== History ==<br />
Acedapsone was developed in the mid-20th century as part of a search for more effective and less toxic [[antileprosy]] drugs. It was first synthesized in 1945 by the Swiss pharmaceutical company [[Ciba]] (now part of [[Novartis]]).<br />
<br />
== Pharmacology ==<br />
Acedapsone is a prodrug of dapsone, which means it is metabolized in the body to produce dapsone. It is more lipophilic than dapsone, which allows it to be stored in fatty tissues and slowly released over time. This gives it a longer duration of action than dapsone, and allows for less frequent dosing.<br />
<br />
== Clinical use ==<br />
Acedapsone is used in the treatment of leprosy, particularly in patients who cannot tolerate dapsone or who have become resistant to it. It is usually given as a monthly injection, in combination with other antileprosy drugs.<br />
<br />
== Side effects ==<br />
Like dapsone, acedapsone can cause a range of side effects, including [[hemolysis]] (destruction of red blood cells), [[methemoglobinemia]] (a condition in which the blood cannot carry enough oxygen), and [[hypersensitivity]] reactions. It can also cause [[neuropathy]] (nerve damage), although this is less common.<br />
<br />
== See also ==<br />
* [[Dapsone]]<br />
* [[Leprosy]]<br />
* [[Sulfone]]<br />
<br />
[[Category:Drugs]]<br />
[[Category:Antileprosy agents]]<br />
[[Category:Sulfones]]<br />
{{pharmacology-stub}}</div>Prab